
Ask a doctor about a prescription for SEDACONDA 100% LIQUID FOR INHALATION
Package Leaflet: Information for the Patient
Sedaconda 100% Liquid for Vapor Inhalation
isoflurane
Read this package leaflet carefully before you start using this medicine, because it contains important information for you.
Contents of the Package Leaflet
This medicine contains the active substance isoflurane, which belongs to a group of medicines called anesthetics. It is used to provide sedation (a state of calmness, drowsiness, or sleep) in adult and pediatric patients from 3 years of age who require mechanical ventilation (a treatment with special machinery that helps patients breathe) during their stay in intensive care.
Do not use Sedaconda
Warnings and Precautions
Talk to your doctor or nurse before you start using this medicine if:
Sedaconda may cause malignant hyperthermia, a rapid and significant rise in body temperature accompanied by muscle stiffness and other symptoms (see section 4).
Sedaconda may cause hyperkalemia (elevated serum potassium levels) in rare cases (see section 4). Patients with neuromuscular disease seem to be the most vulnerable.
Sedaconda may cause breathing difficulties (respiratory depression) (see section 4).
Children and Adolescents
This medicine must not be given to children under 3 years of age, as experience with this medicine is limited in this age group.
Other Medicines and Sedaconda
Tell your doctor or nurse if you are taking, have recently taken, or might take any other medicines.
This is especially important if you are taking any of the following medicines:
Pregnancy, Breast-feeding, and Fertility
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Sedaconda may cause increased blood loss, for example, if you are going to have a uterine operation or give birth. Your doctor will not give you this medicine unless the potential benefit outweighs the potential risks for you and your baby.
If you have been breast-feeding before receiving Sedaconda, you must stop breast-feeding until the medicine has been eliminated from your body. Your doctor will tell you when it is safe for you to continue breast-feeding.
Driving and Using Machines
This medicine may affect your ability to drive and use machines for up to 6 days.
Do not drive or use machines until your doctor tells you it is safe to do so.
Sedaconda will only be given to you by qualified and experienced medical personnel. The doctor will decide the correct dose for you based on your age, health condition, and the level of sedation (drowsiness) you need.
The doctor will give you the correct starting dose to achieve the required level of sedation, carefully observing your responses and vital signs (such as pulse, blood pressure, and breathing, etc.).
Sedaconda is a liquid that turns into vapor (gas) using a vaporizer. It is for inhalation use, which means you will breathe it in as a vapor.
If you receive more Sedaconda than you should
If you are given too much Sedaconda and are in deep sedation, your blood pressure may drop (hypotension) and your breathing may be slow and ineffective. The doctor will take supportive measures to correct blood pressure and breathing.
If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects of unknown frequency (cannot be estimated from the available data):
Side effects reported as frequent (may affect up to 1 in 10 people) in a clinical trial:
Side effects reported as very frequent in children (may affect more than 1 in 10 people) in a clinical trial:
Reporting Side Effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report side effects directly through the Spanish Medicines Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after EXP. The expiry date is the last day of the month shown.
The shelf life of Sedaconda after connection to the Sedaconda Filling Adapter is 14 days.
Do not store above 30°C. Store the vial in the outer packaging to protect it from light.
Disposal of unused medicine and all materials that have come into contact with it should be done in accordance with local regulations.
Composition of Sedaconda
Appearance and Package Contents
Sedaconda is a liquid for vapor inhalation. It is a colorless and transparent liquid, available in 100 ml and 250 ml amber glass bottles.
Package sizes:
6 x 100 ml
6 x 250 ml
Not all package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Sedana Medical AB
Svärdvägen 3A, SE-182 33 Danderyd
Sweden
Manufacturer
Piramal Critical Care B.V.
Rouboslaan 32 (ground floor)
2252 TR, Voorschoten
Netherlands
Local Representative:
Sedana Medical AB, Spanish Branch
Calle Edgar Neville, 27
28020, Madrid
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Sedaconda:Germany, Belgium, Croatia, Denmark, Slovenia, Spain, Italy, Norway, Netherlands, Poland, and Sweden.
Cedaconda:Austria, France
Date of Last Revision of this Package Leaflet:June 2025
------------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals:
Sedaconda 100% Liquid for Vapor Inhalation
Administration
Sedaconda should only be administered and inhaled through the Sedaconda ACD Administration Device, using the Sedaconda Filling Adapter, and should only be used with intubated or tracheotomized patients with protected airways. Sedaconda should only be administered by medical personnel familiar with the management of patients with mechanical ventilation, with Sedaconda ACD, and with the pharmacodynamics of isoflurane.
Isoflurane should only be administered in an adequately equipped environment, by trained personnel in the management of volatile anesthetic agents. To minimize leaks and spills during the use of Sedaconda, adequate general ventilation in the intensive care room, as well as a well-designed exhaust system, appropriate work practices, and routine equipment maintenance, should be ensured.
Sedaconda ACD is a modified passive heat and moisture exchanger (HME) and, as such, adds dead space to the respiratory circuit. The patient's ventilatory status should be taken into account when selecting the size of Sedaconda ACD; refer to the instructions for use provided with Sedaconda ACD.
Complete information on how to use Sedaconda ACD and the Sedaconda Filling Adapter is presented in the Instructions for Use document provided with the devices.
Read the Sedaconda package leaflet and the Instructions for Use provided with Sedaconda ACD and the Sedaconda Filling Adapter before configuring the Sedaconda ACD administration system and starting sedation.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for SEDACONDA 100% LIQUID FOR INHALATION – subject to medical assessment and local rules.